Concepedia

Rolf van Heeswijk

RV

Statistics

Publications

23

Citations

3.5K

H-Index

18

Active since

2004

Affiliations

Vertex Pharmaceuticals (United States)(Current)

Inserm

Medical University of Vienna

Assistance Publique – Hôpitaux de Paris

Université Paris Cité

Rolf van Heeswijk is an author at Vertex Pharmaceuticals (United States) specializing in medicine, hepatitis, and viral hepatitis.

Top concepts

Publications per year

2004–2013

23

Publications

23

Telaprevir for Retreatment of HCV Infection

Stefan Zeuzem, Pietro Andreoné, Stanislas Pol et al. · New England Journal of Medicine · 2011 · 1.5K citations · Full text

Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

Andreas H. Diacon, Peter R. Donald, Alexander S. Pym et al. · Antimicrobial Agents and Chemotherapy · 2012 · 374 citations · Full text

Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis

Roxana Rustomjee, Andreas H. Diacon, Jenny Allen et al. · Antimicrobial Agents and Chemotherapy · 2008 · 276 citations · Full text

Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus

Varun Garg, Rolf van Heeswijk, Jee Eun Lee et al. · Hepatology · 2011 · 261 citations

Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections

Graham R. Foster, Christophe Hézode, Jean–Pierre Bronowicki et al. · Gastroenterology · 2011 · 178 citations · Full text

, , +9

1–5 of 23